Advaxis (ADXS) Reports Q3 Loss of $1.74/Share

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. RNG
2. DECK
3. WDC
4. BYD
5. WCN
6. SPOT
7. BMY
8. SPY
9. FIX
10. TSCO

Go back to Advaxis (ADXS) Reports Q3 Loss of $1.74/Share

Advaxis Reports Business Update and Third Quarter 2017 Results

September 11, 2017 4:01 PM EDT

PRINCETON, N.J.--(BUSINESS WIRE)-- Advaxis, Inc. (NASDAQ: ADXS), a late-stage biotechnology company focused on the discovery, development and commercialization of immunotherapy products, today provided a business update and announced its financial results for the third quarter (Q3) ended July 31, 2017.

The board of directors selected Anthony Lombardo as interim chief executive officer in July, given his 30 years of... More